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CASE REPORT
A novel combination of an IgE mediated 
adult onset food allergy and a suspected 
mast cell activation syndrome presenting 
as anaphylaxis
Colin Barber* and Chrystyna Kalicinsky
Abstract 
Background: Adult onset food allergy is a rare, but increasingly recognized phenomenon. Mast cell activation 
syndromes present an ongoing diagnostic and classification challenge. The combination of the two has been rarely 
described in the literature.
Case presentation: We present a case of a new onset, IgE mediated food allergy in combination with a mast cell 
activation syndrome in an elderly patient not known to have a history of atopy. He presented to a hospital with a first 
presentation of anaphylaxis manifesting profound hypotension following consumption of a stew consisting of fish 
and shellfish. He had a persistently elevated serum tryptase and demonstrated evidence of high titre serum specific 
IgE to shellfish. He responded well to histaminergic blockade.
Conclusions: Given that mast cell activation syndromes pose an increased risk for recurrent, severe anaphylaxis 
and that secondary causes of mast cell activation syndromes are more prevalent with aging, this case highlights the 
importance of considering this entity when evaluating an elderly patient with a first presentation of anaphylaxis.
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Background
Food allergy is reported to affect approximately 2 % of the 
adult population, with the majority having had onset dur-
ing childhood [1, 2]. There is an increasing recognition 
of adult onset food allergy, however these typically are 
associated with pollen-plant association, and are more 
often food-dependent, exercise-induced, anaphylaxis 
(FDEIAn) [3, 4]. Profound cardiovascular derangements 
during anaphylaxis suggest the possibility of an under-
lying mast cell activation syndrome and should prompt 
further investigation [5, 6]. The association between IgE 
mediated Hymenoptera anaphylaxis with hypotension 
and limited cutaneous findings and underlying mast 
cell activation disorders has been well established, and 
guideline recommendations include assessment of a 
serum tryptase, including in patients with negative skin 
prick testing, positive serum specific IgE who have had 
severe anaphylaxis [5].
According to recent consensus statements, mast cell 
activation syndromes are divided into three subtypes: 
Primary mast cell activation syndromes (MCAS), Sec-
ondary MCAS, and idiopathic MCAS. A mast cell acti-
vation disorder requires clinical symptomatology that 
is in keeping with the disorder, a transient, measurable 
increase in either serum tryptase or other markers of 
mast cell mediators and a response to agents that inter-
fere with mast cell mediators [7, 8]. Recent attempts have 
been made to standardize an approach to suspected mast 
cell disorders, in order to appropriately classify individu-
als with evidence of mast cell activation that did not meet 
diagnostic criteria for systemic mastocytosis [7, 8].
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The combination of adult onset food allergy with an 
underlying mast cell disorder has not been described 
previously in the literature, and this case report demon-
strates the investigation of an elderly gentleman who pre-
sented with first onset anaphylaxis due to food ingestion 
with evidence of a suspected underlying mast cell activa-
tion syndrome.
Case presentation
A 75-year-old male presented to the local emergency 
department exhibiting symptoms consistent with anaphy-
laxis. When found by his son in law he was flushed and 
unresponsive. On arrival of  emergency medical person-
nel he was found to be hypotensive with blood pressure 
values of 80/60  mm Hg, hypothermic at 34.7  °C orally, 
and hypoxemic with a sPO2 of 88  % by pulse oximetry. 
He received a 500 cc IV normal saline bolus with EMS. In 
the emergency department he remained hypotensive with 
a blood pressure of 71/44  mm Hg. He was treated with 
3000 cc of IV crystalloid, epinephrine 1:1000 0.3 mg IM 
once, diphenhydramine 25 mg IV with a second 50 mg IV 
dose, ranitidine 150 mg IV once, and methylprednisolone 
250 mg IV once with improvement. He suffered a type 2 
MI, which was felt to be related to anaphylaxis-associated 
hypotension after assessment by Cardiology. A serum 
tryptase value was not obtained by the emergency room 
physician at the time of his presentation.
He had no previous history of anaphylaxis, atopy, lym-
phoproliferative disorder or other neoplasm. His daily 
medications included aspirin 81  mg daily, and this, in 
addition to his other regular medications was continued 
post reaction. He did not take additional doses of aspi-
rin, over the counter or herbal products on the day of 
reaction. He had not been started on any new medica-
tions. There was no family history of atopy. The Allergy 
and Clinical Immunology Service was contacted by the 
emergency physician, at which time the food intake his-
tory was unclear, and given his profound hypotension at 
presentation, a concern of a MCAS was raised. This is 
consistent with suggestions to investigate for MCAS in 
patient’s presenting with anaphylaxis with profound car-
diovascular derangement and lacking documented urti-
caria, even if likely attributed to an IgE mediated reaction 
[5]. He was therefore discharged on cetirizine 10  mg 
orally daily, prednisone 50 mg orally for 5 days, diphen-
hydramine 25–50 mg orally q6 h as needed, and an epi-
nephrine auto-injector. He was subsequently assessed in 
the Adult Allergy and Clinical Immunology outpatient 
clinic.
Between the anaphylactic episode and his appoint-
ment at the Allergy Clinic [approximate time 1  month] 
he consumed Atlantic cod without reaction. A food his-
tory obtained at his first visit revealed his initial event 
had developed following ingestion of a mixed fish and 
shellfish stew, which he had consumed without reaction 
on a regular basis. Following the meal he was alone in 
his room, until being found unresponsive by his son-in-
law 3 h later. The patient could not recall the timeline of 
onset of symptoms, as his recall of the entire event was 
limited. Due to the concern of a potential underlying 
MCAS and the severity of his initial reaction it was felt 
safest to continue H1 receptor antagonist therapy, and 
due to the interference of anti-histamines on skin prick 
testing this was deferred for use of ImmunoCAP® [serum 
specific IgE (Phadia, Sweden)] for shellfish, finned fish 
and Hymenoptera venom. He was given an epinephrine 
auto-injector to be used in the event of subsequent ana-
phylactic reaction. At follow up his serum specific IgE 
was high positive for Shrimp at 13.7 kUA/L, and Crab at 
7.3 kUA/L, moderately positive for Lobster at 2.9 kUA/L 
and Clam at 0.9 kUA/L, while testing negative with val-
ues <0.35 kUA/L for Salmon, Walleye Pike and Whitefish 
[9].
While both skin prick testing and serum specific IgE 
demonstrate the existence of clinical sensitization, they 
do not provide evidence for clinical allergy. Serum spe-
cific IgE has been reported to be in agreement with skin 
prick testing from between 50 and 90 % of the time, with 
average values between 70 and 75 %, and similar values 
in agreement between supervised challenges [10]. The 
interpretation of skin prick tests and serum specific IgE 
requires evaluation of historical features, physical exami-
nation and, at times, supervised challenge [10]. Although 
a supervised oral food challenge would have provided 
definitive evidence of an IgE mediated food allergy 
rather than sensitization, this was not undertaken due 
to the severity of his presentation with development of 
a myocardial infarction, his baseline limited myocardial 
reserve, and multiple comorbidities. It is acknowledged 
this limits the definitive confirmation of IgE mediated 
food allergy, but was made on a risk–benefit decision in 
the best interests of the patient.
A serum tryptase level drawn during his first appoint-
ment at the Allergy Clinic was 15 ng/ml [with a normal 
range from 1 to 11.4 ng/ml], an elevation not diagnostic 
of systemic mastocytosis, but suggestive of a mast cell 
activation disorder [11]. A creatinine obtained dem-
onstrated a value of 92, corresponding to an eGFR of 
>60 ml/min, ruling out reduced renal clearance as a cause 
of accumulation of serum tryptase [12].
To further evaluate for a potential mast cell disor-
der, a 24-h urine methylhistamine level was obtained, 
demonstrating a value of 103  μg/g Cr (normal range 
30–200 μg/g Cr). A serum protein electrophoresis dem-
onstrated no evidence of an M protein. He was seen by 
the Adult Hematology/Oncology Service at Cancer Care 
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Manitoba to definitively exclude a diagnosis of systemic 
mastocytosis, for which a bone marrow biopsy and c-KIT 
testing were completed. His c-KIT mutation testing was 
negative. A bone marrow biopsy demonstrated normal 
trilineage hematopoiesis with normal differentiation and 
maturation without definitive morphological evidence 
of mastocytosis or lymphoma, specifically revealing no 
large lymphoid aggregates, abnormal plasma cells, or 
spindle cells suggestive of mastocytosis. Accompanying 
flow cytometry demonstrated revealed a sample com-
posed of 23 % lymphocytes, of which 84 % were T cells, 
8 % NK cells, and there was a CD4/8 ratio of 0.9. Remain-
ing cells were polyclonal B cells without evidence of lym-
phoma, plasma cell neoplasm, or mastocytosis. Tryptase 
was consistently elevated at 17 ng/ml on repeat testing.
Given his elevated tryptase, he was maintained indefi-
nitely on cetirizine, and continued to avoid both fish and 
shellfish, but did require emergency department moni-
toring following administration of his epinephrine auto 
injector in January 2015 following ingestion of a perogy, 
of which the precise constituents were unknown, and 
development of a diffuse urticarial rash. He was treated 
with a 3 day course of 50 mg of oral prednisone.
He fulfills the proposed diagnostic criteria for diagno-
sis of a suspected MCAS based on guidelines published 
by Valent and colleagues, however we acknowledge the 
challenge of establishing the diagnosis in the context of 
a documented IgE mediated food allergy, and he may be 
best classified as a Secondary MCAS [IgE-dependent dis-
ease related] [7, 8, 13].
Conclusions
The combination of food allergy with a mast cell activa-
tion syndrome with onset in the elderly population repre-
sents a novel combination that is not well described. It is 
unclear whether the patient in this case had an underly-
ing mast cell disorder that was previously quiescent and 
was detected only due to the new development of an IgE 
mediated food allergy, or if sub-clinical sensitization to 
shellfish was able to manifest clinically with acquisition of 
a mast cell disorder. Theoretically the patient could have 
developed proliferation of a non-clonal mast cell popula-
tion due to a subclinical entity such as malignancy, infec-
tion, subclinical thrombosis, an underlying autoimmune 
condition, increased stimulatory cytokines, or increased 
vasoactive peptides; as all are postulated triggers of mast 
cell activation [14].
The increasing prevalence of food allergy worldwide, 
and the heightened propensity for life threatening ana-
phylactic reactions in those with underlying mast cell 
reactivity highlights the importance of an educated, step-
wise, evidence-based diagnostic approach to older adults 
presenting with anaphylaxis. The combination of IgE 
mediated allergy presenting with anaphylaxis associated 
with hypotension and underlying mast cell activation 
disorders is well established in Hymenoptera IgE hyper-
sensitivity, and guideline recommendations to assess for 
serum tryptase exist in this situation [6]. According to a 
recent case series the absence of urticaria or angioedema 
with severe anaphylaxis and associated hypotension in 
response to Hymenoptera stings provides the strongest 
indicator of an underlying mast cell disorder [15]. This 
provides precedence for the combination of IgE medi-
ated anaphylaxis and an underlying mast cell activation 
disorder, and the authors believe this case report high-
lights the importance of a high level of suspicion for mast 
cell disorders in patient’s presenting with anaphylaxis 
with profound cardiovascular manifestations and lim-
ited cutaneous manifestations, as has been previously 
described [5, 16].
A case such as this emphasizes the importance of an 
approach with thorough investigation of all potential 
allergen exposures, including those to which a patient 
has been exposed on multiple occasions without sys-
temic or local reaction. This case suggests the need for 
further elucidation of patient characteristics that pre-
dispose to an underlying mast cell activation syndrome 
despite identification of an IgE mediated trigger, to bet-
ter facilitate identification of patients who would benefit 
from additional intervention with mast cell stabilizing 
therapy.
It could be theorized that new sensitization to previ-
ously tolerated food antigens with resultant anaphylaxis 
could be associated with underlying mast cell activation 
disorders in adults without a history of atopy, particu-
larly when presenting with profound hypotension. Fur-
ther research is needed into the incidence of adult onset 
IgE mediated food allergies, anaphylaxis, and the rate at 
which it is associated with underlying mast cell activa-
tion, particularly given the association with MCAS and 
a heightened risk for a more severe anaphylactic reaction 
[5].
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